Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...

When prescribing an inhaled therapy it is essential ... Better instruction on inhaler technique, and regular reminders, will have an impact on COPD and asthma admission figures, which are so ...

Approved yesterday by the FDA, Trelegy Ellipta is the first ever daily single-inhaler to combine a triple therapy for COPD, and could help patients manage their condition better - around a quarter ...

Comparisons between this literature and reports of current practice suggest that discrepancies may exist in relation to the clinical management of sputum in individuals with COPD. The novel ...

AECOPD describe a sudden, acute onset of COPD symptoms above the patient's usual condition for the disease and are the most commonly caused by respiratory infections. [8] Clinical problems ...

Timing the use of a commonly prescribed asthma inhaler in the mid-afternoon could lead to improved clinical outcomes, ...

“New regulations will give podiatrists the authority to prescribe medicines relating to their role, enabling patients to have more direct access to the medicines for these conditions.